Project Grant P01AI186819
Award Date
4/18/25
Completion Date
3/31/30
Dollars Obligated
$2.1M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $146,922 to Emory University to study factors that influence the efficiency of influenza A virus (IAV) infection. The key research objectives are to: 1) examine the relationship between the intensity of exposure and diversity of viral barcodes under different modes of IAV exposure (direct contact, aerosol); and 2)...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $194,616.00 to Emory University to conduct research on the evolutionary dynamics of influenza A virus (IAV) antigenic evolution. The key objectives are to examine how selection of IAV antigenic mutants occurs within pre-immune hosts and between hosts during transmission. The research utilizes genetically...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $183,541 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Yale University. The funding will support a 5-year investigation of within-household transmission of influenza in low-resource settings in Guatemala, Mozambique, and India. The project aims to quantify influenza spread within households and develop a model to project the effectiveness of interventions like vaccination...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides approximately $1,171,832 to Emory University to conduct research focused on understanding the immune response to influenza infections and informing the development of improved influenza vaccines. The project, titled "Influenza Modeling of Correlates of Protection for Optimal Immune Dynamics and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $744,977.00 to Emory University to explore the role of T cells in protecting against respiratory virus transmission. The key objectives of this 5-year research project are to: 1) define the cellular interactions and molecular mechanisms by which tissue-resident memory T cells (TRM) promote protection against...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $640,735 to Emory University to investigate the characteristics, durability, and molecular mechanisms of respiratory tract tissue-resident memory T cells (TRM) that protect against natural respiratory virus transmission. The research aims to develop a murine model of Sendai virus transmission and new...
This $792,687 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the structural features of sialic acid glycans necessary for influenza virus infection and adaptation across different host species. Key products and services to be delivered under this award include: Utilizing CRISPR/Cas9 technology to define the sialoglycan structural requirements for...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,352,292 in funding to the University of Illinois to conduct high-resolution profiling and computational modeling of influenza virus-immune dynamics during natural infection. The project aims to (1) identify reliable immune correlates of reduced viral shedding and transmission risk, and (2) define how viral...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $239,120 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Tufts University School of Medicine. The grant funding will support research to analyze the heterogeneity of cell death responses in influenza virus-infected cells using a new single-cell RNA sequencing (scRNA-seq) assay called scAnnexinV-seq. The research aims to elucidate the interplay between transcriptional responses...
The federal Project Grant award R01AI184867 in the amount of $596,636.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to determine how optimal protective humoral immunity to influenza infections is induced and maintained, with a focus on understanding the role of B cell intrinsic Toll-like receptor (TLR) signaling pathways in driving extrafollicular B cell...